Attached files

file filename
10-K - FORM 10-K FOR THE FISCAL YEAR ENDED OCTOBER 31, 2014 - MGC DIAGNOSTICS Corpmgc150289_10k.htm
EX-23.1 - CONSENT OF BAKER TILLY VIRCHOW KRAUSE, LLP - MGC DIAGNOSTICS Corpmgc150289_ex23-1.htm
EX-10.9 - POLICY ON DIRECTOR ELECTION OF STOCK IN LIEU OF QUARTERLY RETAINER - MGC DIAGNOSTICS Corpmgc150289_ex10-9.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - MGC DIAGNOSTICS Corpmgc150289_ex31-2.htm
EX-10.11.1 - AMENDMENT NO. 1 TO CREDIT AGREEMENT - MGC DIAGNOSTICS Corpmgc150289_ex10-111.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - MGC DIAGNOSTICS Corpmgc150289_ex31-1.htm
EX-10.13 - $250,000 REVOLVING TERM NOTE - MGC DIAGNOSTICS Corpmgc150289_ex10-13.htm
EX-21 - SUBSIDIARIES OF MGC DIAGNOSTICS CORPORATION - MGC DIAGNOSTICS Corpmgc150289_ex21.htm
EXCEL - IDEA: XBRL DOCUMENT - MGC DIAGNOSTICS CorpFinancial_Report.xls

Exhibit 32

CERTIFICATION

The undersigned certify pursuant to 18 U.S.C. § 1350, that:

 

 

(1)

The accompanying Annual Report on Form 10-K for the period ended October 31, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the accompanying Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


 

 

 

 

 

Date:

January 29, 2015

 

/s/ Todd M. Austin

 

 

 

 

Chief Executive Officer

 

 

 

 

 

 

Date:

January 29, 2015

 

/s/ Wesley W. Winnekins

 

 

 

 

Chief Financial Officer